Share Price and Basic Stock Data
Last Updated: January 20, 2026, 11:24 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Fraser and Company Ltd operates within the Trading & Distributors industry, with a current share price of ₹9.37 and a market capitalization of ₹7.61 Cr. The company has experienced significant fluctuations in revenue, with reported sales of ₹12.80 Cr in FY 2023, a sharp decline from ₹49.11 Cr in FY 2022. Quarterly sales show a downward trend, with ₹0.01 Cr in September 2023 and ₹0.02 Cr in December 2023, indicating a substantial drop in operational activity. The trailing twelve months (TTM) sales stood at ₹0.00, reflecting a complete halt in revenue generation. This suggests that Fraser and Company has been unable to maintain a consistent income stream, raising concerns about its operational viability. In comparison, the average industry sales growth rates indicate that most competitors are actively generating revenue, highlighting Fraser’s struggle to keep pace. The company’s overall revenue trajectory suggests critical challenges in its business model or market positioning.
Profitability and Efficiency Metrics
Fraser and Company Ltd’s profitability has been under significant pressure, with a reported net profit of -₹0.86 Cr. This negative profit trend is consistent throughout the reporting periods, with net losses recorded in multiple quarters, including -₹0.10 Cr in September 2023 and -₹0.17 Cr in December 2023. The operating profit margin (OPM) has also deteriorated, with a staggering OPM of -1,050.00% reported in December 2023, indicating severe inefficiencies. The interest coverage ratio (ICR) is alarming at -161.70x, suggesting that the company’s earnings are insufficient to cover its interest expenses. Additionally, the return on capital employed (ROCE) has plummeted to -24.63% in FY 2025, compared to 6.54% in FY 2023, indicating a significant decline in the effectiveness of capital utilization. These metrics reveal a troubling picture of profitability and operational efficiency, necessitating urgent strategic review and corrective measures.
Balance Sheet Strength and Financial Ratios
The balance sheet of Fraser and Company Ltd shows a current borrowing of ₹0.96 Cr against total liabilities of ₹12.57 Cr, reflecting a manageable debt level with a debt-to-equity ratio of 0.15. However, the company’s reserves are negative at -₹2.95 Cr, indicating a lack of retained earnings and financial health. The book value per share has declined to ₹6.61 in FY 2025, down from ₹9.85 in FY 2023, suggesting diminishing asset value. The current ratio stands at 1.45, indicating a reasonable liquidity position, while the quick ratio mirrors this at 1.45, suggesting that the company can cover its short-term obligations adequately. However, the negative return on equity (ROE) of -29.39% indicates that shareholders are not receiving returns on their investments, which may deter potential investors. Overall, while Fraser has a manageable debt level, the negative reserves and declining book value raise red flags regarding its long-term financial stability.
Shareholding Pattern and Investor Confidence
Fraser and Company Ltd’s shareholding pattern reveals a predominance of public ownership at 96.86%, with promoters holding only 3.12% as of the latest reporting period. This low promoter holding could signal a lack of confidence from the founding shareholders in the company’s future prospects. Institutional ownership is negligible, with domestic institutional investors (DIIs) holding just 0.01%. The number of shareholders has seen fluctuations, peaking at 9,717 in December 2024 before declining to 8,627 in September 2025, suggesting a potential decrease in investor confidence amid ongoing financial challenges. The lack of foreign institutional investment (FIIs) further underscores the company’s struggle to attract institutional backing. This ownership structure, combined with the company’s financial difficulties, may lead to heightened volatility in its stock price, as public sentiment can shift rapidly based on performance.
Outlook, Risks, and Final Insight
The outlook for Fraser and Company Ltd is fraught with challenges, primarily due to its deteriorating financial metrics and lack of operational revenue. The company faces significant risks, including its inability to generate consistent sales, high operational costs, and negative profitability margins. On the other hand, its manageable debt levels and reasonable liquidity ratios provide some buffer against immediate financial distress. For Fraser to recover, it must reassess its business strategy, potentially pivoting to new markets or improving operational efficiencies. If the company can successfully implement corrective measures and restore investor confidence, it may have the potential for recovery. However, without decisive action, the risks of continued losses and stock volatility remain high, making it critical for stakeholders to monitor developments closely and assess future strategic directions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minal Industries Ltd | 58.2 Cr. | 3.03 | 5.59/2.85 | 38.8 | 2.78 | 0.00 % | 5.97 % | 2.83 % | 2.00 |
| Mitshi India Ltd | 10.9 Cr. | 12.4 | 17.9/12.2 | 3.09 | 0.00 % | 0.36 % | 0.37 % | 10.0 | |
| Modella Woollens Ltd | 5.87 Cr. | 64.5 | 74.8/52.5 | 4.95 | 0.00 % | % | % | 10.0 | |
| MRC Agrotech Ltd | 144 Cr. | 45.9 | 54.5/10.2 | 160 | 15.1 | 0.00 % | 5.89 % | 4.46 % | 10.0 |
| MRP Agro Ltd | 95.1 Cr. | 85.6 | 166/84.4 | 13.5 | 30.6 | 0.00 % | 39.2 % | 30.3 % | 10.0 |
| Industry Average | 9,092.76 Cr | 151.83 | 85.13 | 122.20 | 0.43% | 15.37% | 8.86% | 7.71 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.64 | 0.24 | 0.00 | 0.00 | 0.01 | 0.02 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 3.59 | 0.22 | -0.29 | 0.17 | 0.11 | 0.23 | 0.17 | 0.10 | 1.09 | 0.06 | 0.61 | 0.09 | 0.10 |
| Operating Profit | 0.05 | 0.02 | 0.29 | -0.17 | -0.10 | -0.21 | -0.17 | -0.10 | -0.87 | -0.06 | -0.61 | -0.09 | -0.10 |
| OPM % | 1.37% | 8.33% | -1,000.00% | -1,050.00% | -395.45% | ||||||||
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.08 | 0.00 | 0.01 | 0.00 | 0.00 |
| Interest | 0.01 | 0.03 | 0.03 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.00 | 0.04 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 |
| Profit before tax | 0.01 | -0.04 | 0.23 | -0.20 | -0.13 | -0.23 | -0.21 | -0.11 | -0.80 | -0.07 | -0.61 | -0.09 | -0.11 |
| Tax % | 0.00% | -25.00% | 26.09% | -25.00% | -15.38% | -30.43% | 76.19% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.01 | -0.03 | 0.18 | -0.15 | -0.10 | -0.17 | -0.37 | -0.11 | -0.80 | -0.06 | -0.61 | -0.09 | -0.10 |
| EPS in Rs | 0.01 | -0.04 | 0.22 | -0.18 | -0.12 | -0.21 | -0.46 | -0.14 | -0.99 | -0.07 | -0.75 | -0.11 | -0.12 |
Last Updated: December 26, 2025, 11:06 pm
Below is a detailed analysis of the quarterly data for Fraser and Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.10 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.09 Cr. (Jun 2025) to 0.10 Cr., marking an increase of 0.01 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from -0.09 Cr. (Jun 2025) to -0.10 Cr., marking a decrease of 0.01 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Jun 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is -0.11 Cr.. The value appears to be declining and may need further review. It has decreased from -0.09 Cr. (Jun 2025) to -0.11 Cr., marking a decrease of 0.02 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is -0.10 Cr.. The value appears to be declining and may need further review. It has decreased from -0.09 Cr. (Jun 2025) to -0.10 Cr., marking a decrease of 0.01 Cr..
- For EPS in Rs, as of Sep 2025, the value is -0.12. The value appears to be declining and may need further review. It has decreased from -0.11 (Jun 2025) to -0.12, marking a decrease of 0.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:43 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.35 | 0.12 | 0.46 | 0.26 | 0.73 | 4.81 | 25.12 | 37.26 | 49.11 | 12.80 | 0.03 | 0.22 | 0.00 |
| Expenses | 0.09 | 0.95 | 0.35 | 0.30 | 0.85 | 4.76 | 24.17 | 35.74 | 47.49 | 12.14 | 0.68 | 1.85 | 0.86 |
| Operating Profit | 0.26 | -0.83 | 0.11 | -0.04 | -0.12 | 0.05 | 0.95 | 1.52 | 1.62 | 0.66 | -0.65 | -1.63 | -0.86 |
| OPM % | 74.29% | -691.67% | 23.91% | -15.38% | -16.44% | 1.04% | 3.78% | 4.08% | 3.30% | 5.16% | -2,166.67% | -740.91% | |
| Other Income | 0.03 | 0.05 | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 | 0.00 | 0.08 | 0.00 | 0.00 | 0.09 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.03 | 0.08 | 0.04 | 0.01 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.10 | 0.12 | 0.12 | 0.08 | 0.03 | 0.03 |
| Profit before tax | 0.29 | -0.78 | 0.11 | -0.04 | -0.12 | 0.10 | 0.94 | 1.40 | 1.55 | 0.46 | -0.77 | -1.58 | -0.88 |
| Tax % | 0.00% | 0.00% | 63.64% | 0.00% | 0.00% | 30.00% | 23.40% | 25.71% | 25.81% | 26.09% | 37.66% | 0.00% | |
| Net Profit | 0.29 | -0.78 | 0.04 | -0.04 | -0.12 | 0.07 | 0.72 | 1.05 | 1.16 | 0.34 | -1.05 | -1.58 | -0.86 |
| EPS in Rs | 0.51 | -1.36 | 0.07 | -0.07 | -0.21 | 0.09 | 0.89 | 1.29 | 1.43 | 0.42 | -1.29 | -1.95 | -1.05 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -368.97% | 105.13% | -200.00% | -200.00% | 158.33% | 928.57% | 45.83% | 10.48% | -70.69% | -408.82% | -50.48% |
| Change in YoY Net Profit Growth (%) | 0.00% | 474.09% | -305.13% | 0.00% | 358.33% | 770.24% | -882.74% | -35.36% | -81.17% | -338.13% | 358.35% |
Fraser and Company Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -61% |
| 3 Years: | -84% |
| TTM: | 633% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -108% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | 22% |
| 3 Years: | 4% |
| 1 Year: | 46% |
| Return on Equity | |
|---|---|
| 10 Years: | 1% |
| 5 Years: | 0% |
| 3 Years: | -11% |
| Last Year: | -26% |
Last Updated: September 5, 2025, 3:30 pm
Balance Sheet
Last Updated: December 4, 2025, 2:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.72 | 5.72 | 5.72 | 5.72 | 5.72 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 | 8.12 |
| Reserves | -2.59 | -3.37 | -3.33 | -3.37 | -3.50 | -3.39 | -2.68 | -1.62 | -0.47 | -0.12 | -1.18 | -2.75 | -2.95 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.35 | 0.43 | 0.44 | 0.33 | 0.84 | 0.96 |
| Other Liabilities | 2.64 | 3.41 | 3.44 | 0.27 | 0.64 | 0.80 | 4.58 | 14.93 | 7.20 | 8.54 | 7.32 | 6.52 | 6.44 |
| Total Liabilities | 5.77 | 5.76 | 5.83 | 2.62 | 2.86 | 5.53 | 10.02 | 21.78 | 15.28 | 16.98 | 14.59 | 12.73 | 12.57 |
| Fixed Assets | 0.00 | 0.00 | 0.01 | 0.00 | 0.01 | 0.06 | 0.08 | 0.47 | 0.53 | 0.29 | 0.22 | 0.06 | 0.06 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.77 | 5.76 | 5.82 | 2.62 | 2.85 | 5.47 | 9.94 | 21.31 | 14.75 | 16.69 | 14.37 | 12.67 | 12.51 |
| Total Assets | 5.77 | 5.76 | 5.83 | 2.62 | 2.86 | 5.53 | 10.02 | 21.78 | 15.28 | 16.98 | 14.59 | 12.73 | 12.57 |
Below is a detailed analysis of the balance sheet data for Fraser and Company Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.12 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.12 Cr..
- For Reserves, as of Sep 2025, the value is -2.95 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -2.75 Cr. (Mar 2025) to -2.95 Cr., marking a decline of 0.20 Cr..
- For Borrowings, as of Sep 2025, the value is 0.96 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 0.84 Cr. (Mar 2025) to 0.96 Cr., marking an increase of 0.12 Cr..
- For Other Liabilities, as of Sep 2025, the value is 6.44 Cr.. The value appears to be improving (decreasing). It has decreased from 6.52 Cr. (Mar 2025) to 6.44 Cr., marking a decrease of 0.08 Cr..
- For Total Liabilities, as of Sep 2025, the value is 12.57 Cr.. The value appears to be improving (decreasing). It has decreased from 12.73 Cr. (Mar 2025) to 12.57 Cr., marking a decrease of 0.16 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.06 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.06 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 12.51 Cr.. The value appears to be declining and may need further review. It has decreased from 12.67 Cr. (Mar 2025) to 12.51 Cr., marking a decrease of 0.16 Cr..
- For Total Assets, as of Sep 2025, the value is 12.57 Cr.. The value appears to be declining and may need further review. It has decreased from 12.73 Cr. (Mar 2025) to 12.57 Cr., marking a decrease of 0.16 Cr..
However, the Borrowings (0.96 Cr.) are higher than the Reserves (-2.95 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.26 | -0.83 | 0.11 | -0.04 | -0.12 | 0.05 | 0.95 | 1.17 | 1.19 | 0.22 | -0.98 | -2.47 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 938.57 | 3,132.92 | 1,063.26 | 2,175.96 | 940.00 | 274.70 | 120.17 | 164.48 | 91.49 | 316.81 | 116,921.67 | 15,943.86 |
| Inventory Days | 0.00 | 0.00 | 6.77 | 3.41 | 2.27 | 0.83 | 0.00 | 0.00 | 0.00 | |||
| Days Payable | 60.97 | 68.68 | 161.29 | 50.59 | ||||||||
| Cash Conversion Cycle | 938.57 | 3,132.92 | 1,063.26 | 2,175.96 | 940.00 | 220.50 | 54.89 | 5.46 | 41.73 | 316.81 | 116,921.67 | 15,943.86 |
| Working Capital Days | 2,888.71 | 6,661.25 | 1,745.65 | 3,299.04 | 1,105.00 | 265.59 | 67.28 | 33.01 | 46.90 | 119.77 | 32,606.67 | 4,977.27 |
| ROCE % | 48.74% | -28.47% | 4.64% | -1.69% | -5.25% | 2.88% | 18.49% | 23.11% | 21.17% | 6.54% | -9.29% | -24.63% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.94 | -1.30 | 0.42 | 1.43 | 1.30 |
| Diluted EPS (Rs.) | -1.94 | -1.30 | 0.42 | 1.43 | 1.30 |
| Cash EPS (Rs.) | -1.90 | -1.21 | 0.56 | 1.57 | 1.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 6.61 | 8.55 | 9.85 | 9.43 | 8.00 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 6.61 | 8.55 | 9.85 | 9.43 | 8.00 |
| Revenue From Operations / Share (Rs.) | 0.26 | 0.03 | 15.77 | 60.48 | 45.88 |
| PBDIT / Share (Rs.) | -1.89 | -0.80 | 0.81 | 2.09 | 1.88 |
| PBIT / Share (Rs.) | -1.93 | -0.89 | 0.66 | 1.95 | 1.76 |
| PBT / Share (Rs.) | -1.94 | -0.94 | 0.57 | 1.91 | 1.73 |
| Net Profit / Share (Rs.) | -1.94 | -1.30 | 0.42 | 1.43 | 1.29 |
| PBDIT Margin (%) | -702.63 | -2384.84 | 5.16 | 3.45 | 4.08 |
| PBIT Margin (%) | -717.62 | -2659.83 | 4.22 | 3.21 | 3.83 |
| PBT Margin (%) | -721.97 | -2809.98 | 3.62 | 3.16 | 3.77 |
| Net Profit Margin (%) | -721.04 | -3865.51 | 2.67 | 2.35 | 2.82 |
| Return on Networth / Equity (%) | -29.39 | -15.18 | 4.27 | 15.13 | 16.18 |
| Return on Capital Employeed (%) | -26.21 | -9.53 | 5.72 | 17.47 | 19.20 |
| Return On Assets (%) | -12.39 | -7.22 | 2.52 | 7.58 | 4.82 |
| Long Term Debt / Equity (X) | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.15 | 0.04 | 0.01 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.01 | 0.00 | 0.88 | 2.65 | 2.34 |
| Current Ratio (X) | 1.45 | 1.39 | 2.79 | 2.07 | 1.37 |
| Quick Ratio (X) | 1.45 | 1.39 | 2.79 | 2.06 | 1.36 |
| Interest Coverage Ratio (X) | -161.70 | -15.88 | 8.59 | 60.79 | 74.10 |
| Interest Coverage Ratio (Post Tax) (X) | -164.93 | -24.74 | 5.44 | 42.48 | 52.16 |
| Enterprise Value (Cr.) | 8.26 | 4.17 | 4.66 | 6.16 | 1.63 |
| EV / Net Operating Revenue (X) | 37.76 | 153.05 | 0.36 | 0.12 | 0.04 |
| EV / EBITDA (X) | -5.37 | -6.42 | 7.05 | 3.62 | 1.07 |
| MarketCap / Net Operating Revenue (X) | 34.15 | 143.80 | 0.36 | 0.13 | 0.09 |
| Price / BV (X) | 1.39 | 0.56 | 0.57 | 0.85 | 0.54 |
| Price / Net Operating Revenue (X) | 34.20 | 146.36 | 0.36 | 0.13 | 0.09 |
| EarningsYield | -0.21 | -0.26 | 0.07 | 0.17 | 0.29 |
After reviewing the key financial ratios for Fraser and Company Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 5. It has decreased from -1.30 (Mar 24) to -1.94, marking a decrease of 0.64.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 5. It has decreased from -1.30 (Mar 24) to -1.94, marking a decrease of 0.64.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.90. This value is below the healthy minimum of 3. It has decreased from -1.21 (Mar 24) to -1.90, marking a decrease of 0.69.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.61. It has decreased from 8.55 (Mar 24) to 6.61, marking a decrease of 1.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 6.61. It has decreased from 8.55 (Mar 24) to 6.61, marking a decrease of 1.94.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.26. It has increased from 0.03 (Mar 24) to 0.26, marking an increase of 0.23.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -1.89. This value is below the healthy minimum of 2. It has decreased from -0.80 (Mar 24) to -1.89, marking a decrease of 1.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is -1.93. This value is below the healthy minimum of 0. It has decreased from -0.89 (Mar 24) to -1.93, marking a decrease of 1.04.
- For PBT / Share (Rs.), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 0. It has decreased from -0.94 (Mar 24) to -1.94, marking a decrease of 1.00.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.94. This value is below the healthy minimum of 2. It has decreased from -1.30 (Mar 24) to -1.94, marking a decrease of 0.64.
- For PBDIT Margin (%), as of Mar 25, the value is -702.63. This value is below the healthy minimum of 10. It has increased from -2,384.84 (Mar 24) to -702.63, marking an increase of 1,682.21.
- For PBIT Margin (%), as of Mar 25, the value is -717.62. This value is below the healthy minimum of 10. It has increased from -2,659.83 (Mar 24) to -717.62, marking an increase of 1,942.21.
- For PBT Margin (%), as of Mar 25, the value is -721.97. This value is below the healthy minimum of 10. It has increased from -2,809.98 (Mar 24) to -721.97, marking an increase of 2,088.01.
- For Net Profit Margin (%), as of Mar 25, the value is -721.04. This value is below the healthy minimum of 5. It has increased from -3,865.51 (Mar 24) to -721.04, marking an increase of 3,144.47.
- For Return on Networth / Equity (%), as of Mar 25, the value is -29.39. This value is below the healthy minimum of 15. It has decreased from -15.18 (Mar 24) to -29.39, marking a decrease of 14.21.
- For Return on Capital Employeed (%), as of Mar 25, the value is -26.21. This value is below the healthy minimum of 10. It has decreased from -9.53 (Mar 24) to -26.21, marking a decrease of 16.68.
- For Return On Assets (%), as of Mar 25, the value is -12.39. This value is below the healthy minimum of 5. It has decreased from -7.22 (Mar 24) to -12.39, marking a decrease of 5.17.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.15. This value is within the healthy range. It has increased from 0.04 (Mar 24) to 0.15, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 1.45. This value is below the healthy minimum of 1.5. It has increased from 1.39 (Mar 24) to 1.45, marking an increase of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 1.45. This value is within the healthy range. It has increased from 1.39 (Mar 24) to 1.45, marking an increase of 0.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -161.70. This value is below the healthy minimum of 3. It has decreased from -15.88 (Mar 24) to -161.70, marking a decrease of 145.82.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -164.93. This value is below the healthy minimum of 3. It has decreased from -24.74 (Mar 24) to -164.93, marking a decrease of 140.19.
- For Enterprise Value (Cr.), as of Mar 25, the value is 8.26. It has increased from 4.17 (Mar 24) to 8.26, marking an increase of 4.09.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 37.76. This value exceeds the healthy maximum of 3. It has decreased from 153.05 (Mar 24) to 37.76, marking a decrease of 115.29.
- For EV / EBITDA (X), as of Mar 25, the value is -5.37. This value is below the healthy minimum of 5. It has increased from -6.42 (Mar 24) to -5.37, marking an increase of 1.05.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 34.15. This value exceeds the healthy maximum of 3. It has decreased from 143.80 (Mar 24) to 34.15, marking a decrease of 109.65.
- For Price / BV (X), as of Mar 25, the value is 1.39. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 1.39, marking an increase of 0.83.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 34.20. This value exceeds the healthy maximum of 3. It has decreased from 146.36 (Mar 24) to 34.20, marking a decrease of 112.16.
- For EarningsYield, as of Mar 25, the value is -0.21. This value is below the healthy minimum of 5. It has increased from -0.26 (Mar 24) to -0.21, marking an increase of 0.05.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Fraser and Company Ltd:
- Net Profit Margin: -721.04%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -26.21% (Industry Average ROCE: 15.37%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -29.39% (Industry Average ROE: 8.86%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -164.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.45
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 85.13)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.15
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -721.04%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Trading & Distributors | House No.12, Plot 6A, Ground Floor, SNEH Road, No.2 Abhinav Nagar, Mumbai Maharashtra 400066 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Omkar Rajkumar Shivhare | Managing Director |
| Mr. Vijay Solanki | Executive Director & CFO |
| Mr. Vinod Gopaldas Gulrajani | Independent Director |
| Mr. Raj Kumar Rajpurohi | Independent Director |
| Ms. Yogeeta Rajkumar Shivhare | Executive Director |
FAQ
What is the intrinsic value of Fraser and Company Ltd?
Fraser and Company Ltd's intrinsic value (as of 20 January 2026) is ₹16.47 which is 94.68% higher the current market price of ₹8.46, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹6.87 Cr. market cap, FY2025-2026 high/low of ₹12.3/5.40, reserves of ₹-2.95 Cr, and liabilities of ₹12.57 Cr.
What is the Market Cap of Fraser and Company Ltd?
The Market Cap of Fraser and Company Ltd is 6.87 Cr..
What is the current Stock Price of Fraser and Company Ltd as on 20 January 2026?
The current stock price of Fraser and Company Ltd as on 20 January 2026 is ₹8.46.
What is the High / Low of Fraser and Company Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Fraser and Company Ltd stocks is ₹12.3/5.40.
What is the Stock P/E of Fraser and Company Ltd?
The Stock P/E of Fraser and Company Ltd is .
What is the Book Value of Fraser and Company Ltd?
The Book Value of Fraser and Company Ltd is 6.37.
What is the Dividend Yield of Fraser and Company Ltd?
The Dividend Yield of Fraser and Company Ltd is 0.00 %.
What is the ROCE of Fraser and Company Ltd?
The ROCE of Fraser and Company Ltd is 24.6 %.
What is the ROE of Fraser and Company Ltd?
The ROE of Fraser and Company Ltd is 27.1 %.
What is the Face Value of Fraser and Company Ltd?
The Face Value of Fraser and Company Ltd is 10.0.